NCT07529847Recruiting
Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
Source: ClinicalTrials.gov · Last updated 14 Apr 2026
Brief summary (registry, in English)
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- First submitted
- 28 Mar 2026
- Start date
- 28 Feb 2026
- Primary completion date
- 15 May 2026
- Lead sponsor
- Foundation University Islamabad
- Diseases
- Asthma
- NCT number
- NCT07529847
What you commit to
- Study type: Interventional
- Planned participants: 46
- From 28 Feb 2026 to the primary completion date, 15 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients diagnosed with acute infection
Other
- Patients having acute exerbation of COPD/status asthmaticus
- Patients unable to follow command and instructions
- Asthma patients with \>40sec control pause duration
Who the study is looking for
- Age between 18-45 years
- Both genders (male and female)
- Grade 1-3 on mMRC scale of dyspnea
- Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020)
Age in the registry: 18 years to 45 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Foundation University, Islamabad Coordinator of this site? Confirm its status | Islamabad | Pakistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.